Progynova provides hormone replacement therapy (HRT for the treatment of climacteric complaints after the cessation of monthly bleeding or after removal of the ovaries (ovariectomy) In addition, it is employed for preventing the bone disease in later life, so-called postmenopausal osteoporosis. Progynova contains estradiol valerate, a prodrug of the 

natural human estradiol. During "the change of life' the estradiol production of the ovaries declines. Although the change of life is natural, it often causes distressing symptoms, which are connected with the gradual loss of the hormones produced by the ovaries. In addition the loss of these hormones may, in some women, lead to thinning of the bones in later 

life (postmenopausal osteoporosis) Progynova replaces the hormone estradiol. The estradiol prevents or relieves symptoms such as hot flushes, sweats, sleep disturbances, nervousness, irritability, dizziness, headaches as well as involuntary loss of urine, vaginal dryness and burning If you still have a womb (you have not had a hysterectomy)

Indications: oestrogen hormonal therapy

Direction : Progynova 2mg tablet is to be taken daily. It does not matter at what time of day the woman takes her tablet, but she has to select a particular time slot and should keep it same every day without any delay. Treatment is continuous, which means that the next pack follows the other one immediately without a break.

Possible side effects of Progynova 2mg are Breast tenderness and pain, vomiting and nausea, headache, hypertension, eye disorders, Sexual Dysfunction.

Caution : Progynova2 mg tablets should not be consumed by pregnant or breastfeeding ladies. The effect of this medicine can be seen within 14-30 days of administration and lasts for 7-14 days after the medicine is stopped.

Package Contents: 3 blisters of 28 tablets each with oestradiol valerate 2 mg in each tablet – total 84 tablets

Storage : Store at controlled room temperature of 59° - 86°F. (15°- 30°C).